本页面由Tiger Trade Technology Pte. Ltd.提供服务

奥麦罗制药

18.88
-0.7500-3.82%
盘后:18.980.1006+0.53%19:30 EDT
成交量:99.41万
成交额:1,918.35万
市值:13.66亿
市盈率:12.02
高:19.78
开:19.50
低:18.83
收:19.63
52周最高:21.24
52周最低:4.06
股本:7,237.54万
流通股本:6,825.80万
量比:1.13
换手率:1.46%
股息:- -
股息率:- -
每股收益(TTM):1.57
每股收益(LYR):-0.0527
净资产收益率:-576.33%
总资产收益率:-18.68%
市净率:-26.61
市盈率(LYR):-357.94

数据加载中...

2021/06/16

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/06/16

重要事件披露

8-K - Current report
2021/05/20

重要事件披露

8-K - Current report
2021/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/03/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/01

重要事件披露

8-K - Current report
2021/02/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/09

重要事件披露

8-K - Current report
2020/08/14

重要事件披露

8-K - Current report
2020/08/12

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/10

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]